pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·5h ago·1 min read
save

InstallatørGruppen reports insider share transaction involving board members' associate

Aug 6, 2026·read at globenewswire health ↗RegulatoryNeutral

InstallatørGruppen A/S has filed a Market Abuse Regulation (EU) No. 596/2014 notification under article 19, disclosing a recent share transaction.

The transaction was executed by Absalon Holdings Limited, which is described as a legal person closely associated with two members of the board, Christian Erik Bering Jelsbech and Eskil Gundersen Koffeld.

The company attached the full notification for review and provided contact details for its communications and investor‑relations teams. InstallatørGruppen provides multi‑disciplinary technical installation services in Denmark and Switzerland, covering plumbing, heating, ventilation, refrigeration, electrical systems and related energy‑transition solutions.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Regulatory announcement no 19: Reporting of transactions made by persons discharging managerial responsibilities and their closely associated persons in InstallatørGruppen's shares”

read at globenewswire health ↗
178 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING

related stories

  • May 8OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive
  • May 8Why we left the FDA: Six former officials share their storiesSTAT
  • May 8Opinion: We need more men in nursingSTAT
  • May 7Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papersSTAT
  • May 7Sarepta tumbles as its gene therapy sales decline furtherBioPharma Dive